Literature DB >> 21940491

Gene expression networks in COPD: microRNA and mRNA regulation.

Michael E Ezzie1, Melissa Crawford, Ji-Hoon Cho, Robert Orellana, Shile Zhang, Richard Gelinas, Kara Batte, Lianbo Yu, Gerard Nuovo, David Galas, Philip Diaz, Kai Wang, S Patrick Nana-Sinkam.   

Abstract

BACKGROUND: The mechanisms underlying chronic obstructive pulmonary disease (COPD) remain unclear. MicroRNAs (miRNAs or miRs) are small non-coding RNA molecules that modulate the levels of specific genes and proteins. Identifying expression patterns of miRNAs in COPD may enhance our understanding of the mechanisms of disease. A study was undertaken to determine if miRNAs are differentially expressed in the lungs of smokers with and without COPD. miRNA and mRNA expression were compared to enrich for biological networks relevant to the pathogenesis of COPD.
METHODS: Lung tissue from smokers with no evidence of obstructive lung disease (n=9) and smokers with COPD (n=26) was examined for miRNA and mRNA expression followed by validation. We then examined both miRNA and mRNA expression to enrich for relevant biological pathways.
RESULTS: 70 miRNAs and 2667 mRNAs were differentially expressed between lung tissue from subjects with COPD and smokers without COPD. miRNA and mRNA expression profiles enriched for biological pathways that may be relevant to the pathogenesis of COPD including the transforming growth factor β, Wnt and focal adhesion pathways. miR-223 and miR-1274a were the most affected miRNAs in subjects with COPD compared with smokers without obstruction. miR-15b was increased in COPD samples compared with smokers without obstruction and localised to both areas of emphysema and fibrosis. miR-15b was differentially expressed within GOLD classes of COPD. Expression of SMAD7, which was validated as a target for miR-15b, was decreased in bronchial epithelial cells in COPD.
CONCLUSIONS: miRNA and mRNA are differentially expressed in individuals with COPD compared with smokers without obstruction. Investigating these relationships may further our understanding of the mechanisms of disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21940491     DOI: 10.1136/thoraxjnl-2011-200089

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  136 in total

1.  Integrated Genomics Reveals Convergent Transcriptomic Networks Underlying Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis.

Authors:  Rebecca L Kusko; John F Brothers; John Tedrow; Kusum Pandit; Luai Huleihel; Catalina Perdomo; Gang Liu; Brenda Juan-Guardela; Daniel Kass; Sherry Zhang; Marc Lenburg; Fernando Martinez; John Quackenbush; Frank Sciurba; Andrew Limper; Mark Geraci; Ivana Yang; David A Schwartz; Jennifer Beane; Avrum Spira; Naftali Kaminski
Journal:  Am J Respir Crit Care Med       Date:  2016-10-15       Impact factor: 21.405

Review 2.  MicroRNA: master controllers of intracellular signaling pathways.

Authors:  Pak-Yin Lui; Dong-Yan Jin; Nigel J Stevenson
Journal:  Cell Mol Life Sci       Date:  2015-06-10       Impact factor: 9.261

3.  Kinetics of microRNA Expression in Bronchoalveolar Lavage Fluid Samples.

Authors:  Matthias Brock; Thomas Rechsteiner; Malcolm Kohler; Daniel Franzen; Lars C Huber
Journal:  Lung       Date:  2015-03-21       Impact factor: 2.584

4.  Shifting from Correlation to Causation: Challenges for the Future of Unbiased Molecular Studies in Inflammatory Lung Disease.

Authors:  Stephanie A Christenson; Katrina Steiling
Journal:  Am J Respir Crit Care Med       Date:  2017-01-01       Impact factor: 21.405

5.  The Akt inhibitor, triciribine, ameliorates chronic hypoxia-induced vascular pruning and TGFβ-induced pulmonary fibrosis.

Authors:  Maha Abdalla; Harika Sabbineni; Roshini Prakash; Adviye Ergul; Susan C Fagan; Payaningal R Somanath
Journal:  Br J Pharmacol       Date:  2015-07-06       Impact factor: 8.739

6.  Plasma levels of miR-137 and miR-124 are associated with Parkinson's disease but not with Parkinson's disease with depression.

Authors:  Na Li; Xudong Pan; Jingli Zhang; Aijun Ma; Shaonan Yang; Juanjuan Ma; Anmu Xie
Journal:  Neurol Sci       Date:  2017-02-08       Impact factor: 3.307

7.  The DNA repair transcriptome in severe COPD.

Authors:  Maor Sauler; Maxime Lamontagne; Eric Finnemore; Jose D Herazo-Maya; John Tedrow; Xuchen Zhang; Julia E Morneau; Frank Sciurba; Wim Timens; Peter D Paré; Patty J Lee; Naftali Kaminski; Yohan Bossé; Jose L Gomez
Journal:  Eur Respir J       Date:  2018-10-04       Impact factor: 16.671

8.  Enhancement of COPD biological networks using a web-based collaboration interface.

Authors:  Stephanie Boue; Brett Fields; Julia Hoeng; Jennifer Park; Manuel C Peitsch; Walter K Schlage; Marja Talikka; Ilona Binenbaum; Vladimir Bondarenko; Oleg V Bulgakov; Vera Cherkasova; Norberto Diaz-Diaz; Larisa Fedorova; Svetlana Guryanova; Julia Guzova; Galina Igorevna Koroleva; Elena Kozhemyakina; Rahul Kumar; Noa Lavid; Qingxian Lu; Swapna Menon; Yael Ouliel; Samantha C Peterson; Alexander Prokhorov; Edward Sanders; Sarah Schrier; Golan Schwaitzer Neta; Irina Shvydchenko; Aravind Tallam; Gema Villa-Fombuena; John Wu; Ilya Yudkevich; Mariya Zelikman
Journal:  F1000Res       Date:  2015-01-29

9.  Progressive Control of Streptococcus agalactiae-Induced Innate Inflammatory Response Is Associated with Time Course Expression of MicroRNA-223 by Neutrophils.

Authors:  Maud Deny; Marta Romano; Olivier Denis; Georges Casimir; Mustapha Chamekh
Journal:  Infect Immun       Date:  2020-11-16       Impact factor: 3.441

10.  miR-15b/16-2 regulates factors that promote p53 phosphorylation and augments the DNA damage response following radiation in the lung.

Authors:  Mohammad Rahman; Francesca Lovat; Giulia Romano; Federica Calore; Mario Acunzo; Erica Hlavin Bell; Patrick Nana-Sinkam
Journal:  J Biol Chem       Date:  2014-08-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.